NASH Summit 2020
Digital, 15-18 Dec 2020
We are looking forward to attending the 4th Annual NASH Summit digitally on 15th - 18th December.
This conference gathers NASH drug developers to share their thoughts across discovery, translational, non-invasive biomarker and clinical drug development tracks, as well as new content on clinical safety, pathological fibrosis and market access. There will be 80+ speakers and 350+ attendees.
Howard Kartstein, Senior Business Development Manager at Owlstone Medical, will be representing us at this meeting.
To meet with us at this event, please get in touch.
Learn more about breath biomarkers for disease in our free ebook: Breath Biopsy: The Complete Guide.